MSB 7.69% $1.19 mesoblast limited

Ann: Positive Heart Failure Trial Results Present, page-4

  1. 333 Posts.
    re: Ann: Positive Heart Failure Trial Results... good results but just concerned mesoblast has been upstaged with the other trial that used cardiac stem cells.

    based on these results,cardiac stem cells are more much more effective than MSB's bone marrow derived mpc's..wonder what - if any - implications this may have for revascor,phase 3 trials and eventual commercialisation'

    MT79
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.